An experimental drug combination was able to effectively treat pancreatic cancer in mouse models without tumor resistance.

Venous thromboembolism is associated with worse survival in patients with pancreatic ductal adenocarcinoma receiving ...

One in three people will be diagnosed with cancer in their lifetime, with pancreatic cancer one of the deadliest among them.

Cold Spring Harbor Laboratory postdoc Jeremy Nigri and colleagues in the Tuveson lab have discovered that the nervous system ...

The biochemist’s company, Vega Oncotargets, has toned down its message after the false expectations generated by the ...

Researchers found that nerves and cancer-supporting cells team up early to drive pancreatic cancer—breaking that alliance could weaken the disease before it fully forms.

Pancreatic cancer, known for its aggressiveness, has seen limited improvements in survival rates over the past decade.

A Mayo Clinic study is providing new insights into how treatment sequence can affect survival in patients with early-stage pancreatic cancer, suggesting that many patients may benefit from receiving ...

A Mayo Clinic study is providing new insights into how treatment sequence can affect survival in patients with early-stage ...

Notoriously tricky to detect, pancreatic cancer also often resists traditional therapy. So, researchers are urgently looking for new ways to disrupt tumor formation. Though scientists know that the ...

Pancreatic cancer accounts for about 3 percent of all cancers, but it causes around 7 percent of all cancer deaths. In 2022, the World Health Organiza.

Dr. Asfar Azmi is a Associate Professor of Oncology at Wayne State University School of Medicine. He talks with FOX 2's ...